How Quitting Smoking Can Quickly Lower Risk Of A-Fib
Smokers who make the decision to quit will experience immediate health benefits, including a rapid reduction in their risk of atrial fibrillation (A-Fib), according to new research published in JACC: Clinical Electrophysiology. The study, conducted by Dr. Gregory Marcus, a cardiologist at the University of California, San Francisco, offers compelling evidence for smokers to quit, showing that it’s never too late to avoid the damaging effects of smoking on heart health.
Dr. Marcus, the senior author of the study, emphasized that A-Fib can be prevented even in individuals who have smoked for years. "The findings provide a compelling new reason to show current smokers that it’s not too late to quit, and that having smoked in the past doesn’t mean you’re ‘destined’ to develop A-Fib," Marcus explained. "Even for the current and longtime smoker, A-Fib can still be avoided."
"There’s strong evidence that smoking increases the risk of A-Fib," Marcus said. "But the benefits of quitting smoking have been less certain." With this in mind, his team sought to determine whether quitting could significantly lower a person’s risk of developing A-Fib, or if the risk would remain the same.
The research team analyzed data from over 146,700 current and former smokers, tracking their smoking habits and health over a 12-year period using data from the UK Biobank database. The results were promising: former smokers had a 13% lower risk of developing A-Fib compared to current smokers, while those who quit during the study saw an 18% reduction in their risk.
"This is likely a testament to the potency of reducing atrial fibrillation risk pretty shortly after quitting," Marcus said in a statement from the American College of Cardiology.
The findings highlight the importance of quitting smoking, not only for general health but specifically for reducing the risk of serious heart conditions like A-Fib.
Quitting smoking is one of the most effective ways to lower the risk of A-Fib and improve overall heart health. While it can be challenging, the benefits of quitting are clear and immediate. Here are some tips to help you quit smoking successfully:
1. Choose a specific date to quit smoking and stick to it. Prepare yourself mentally and physically for this change.
2. Reach out to family, friends, or a support group to help keep you accountable. Sharing your goals with others can provide encouragement.
3. Options like nicotine patches, gum, or lozenges can help ease withdrawal symptoms and reduce cravings.
4. Identify situations that make you want to smoke, such as stress or social gatherings, and find healthy ways to cope with them.
5. Regular exercise can help distract you from cravings and improve your mood during the quitting process.
6. Drinking water can help flush nicotine out of your system faster, reducing cravings.
7. Activities like yoga, meditation, or deep breathing exercises can help manage stress, a common trigger for smoking.
Quitting smoking offers immediate and significant benefits, particularly in reducing the risk of atrial fibrillation. The latest research provides smokers with more motivation to quit, showing that it's never too late to take control of their heart health.
Credit: iStock
Could chewing gum one day help fight cancer? Researchers at the University of Pennsylvania in the US have developed an experimental gum made from lablab beans, also known as Indian beans, that targets human papillomavirus (HPV) and harmful oral bacteria associated with head and neck cancer.
In laboratory tests using oral samples from cancer patients, extracts of the gum reduced HPV levels by up to 93%. An enhanced version also reduced two harmful bacterial species to nearly undetectable levels without affecting the beneficial bacteria tested.
The experimental gum builds on the team's earlier research into lablab beans. It contains FRIL, a naturally occurring plant protein with antiviral properties.
Researchers tested gum extracts against microorganisms in oral samples collected from patients with head and neck cancer.
The results published in Scientific Reports journal showed:
The researchers also developed an enhanced version containing protegrin, an antimicrobial peptide. Peptides are short chains of amino acids, the building blocks of proteins.
A single dose of the enhanced gum extract reduced two targeted bacterial species, Porphyromonas gingivalis (Pg) and Fusobacterium nucleatum (Fn), to nearly undetectable levels.
Also read: HPV Vaccines Can Prevent Head And Neck Cancers In Men, Says Study
The experimental formulation selectively targeted harmful bacteria while leaving the beneficial bacterial populations examined in the study largely unaffected.
The oral microbiome, which consists of microorganisms living inside the mouth, plays an important role in maintaining oral health.
Cancer treatments such as radiation therapy can disrupt this microbial balance, reducing beneficial bacteria and encouraging the growth of potentially harmful microorganisms, including Candida albicans, a type of yeast.
The researchers suggest that selectively targeting harmful microbes while preserving beneficial ones could be particularly useful for patients undergoing cancer treatment.
Read More: Russia's mRNA Cancer Vaccine: First Patient With Melanoma Completes Treatment, Shows No New Tumours
The researchers believe the findings warrant further investigation through human clinical trials. They envision the technology potentially being used alongside existing cancer treatments or as a preventive approach to limit infections.
"Lip and oral cavity cancer was the seventh leading cancer type in cancer incidence and mortality rate worldwide in adolescents, young adults, and middle-aged adults in 2022," Daniell said.
He said the findings support advancing these therapies into clinical trials as additional treatments or as prophylaxis to prevent infection and transmission.
Prophylaxis refers to measures taken to prevent a disease or infection before it occurs.
The plant-based technology could also offer a potentially affordable way to deliver protective proteins directly into the mouth.
However, the findings should be interpreted cautiously. The researchers tested gum extracts on patient samples under laboratory conditions. They have not established whether chewing the gum produces the same results in people or whether reducing these microorganisms can prevent cancer or improve treatment outcomes.
Human clinical trials will be needed to establish its safety and effectiveness. For now, the bean-based gum remains experimental and is not a proven cancer-prevention or treatment option.
Credit: iStock
With one in six laboratory-confirmed bacterial infections worldwide already resistant to antibiotics, drug-resistant infections could contribute to more than 39 million deaths by 2050 if current trends persist, according to the World Health Organization (WHO).
Speaking at the virtual 6th Annual Global Media Forum on AMR, WHO officials warned that countries are not doing enough to tackle antimicrobial resistance (AMR), despite growing commitments. They also presented findings from the latest joint survey by WHO, the United Nations Environment Programme, the World Organisation for Animal Health and the Food and Agriculture Organization.
Although more countries have adopted national action plans to combat AMR, most have failed to translate these commitments into funded and implemented programmes. As a result, the world remains off track to meet key 2030 targets.
Of the 183 countries surveyed, 173 reported having a national action plan, up from 79 in 2017. However, only 42 said their plans were financed and implemented.
Also read: Over One In Four Americans Lied To Get Antibiotics For Children: Why It Can Be Dangerous
Antimicrobial resistance occurs when bacteria, viruses, fungi and parasites evolve and no longer respond to medicines designed to treat them. This makes infections harder to treat and increases the risk of disease spread, severe illness and death.
Antibiotic resistance is a form of AMR that specifically involves bacteria becoming resistant to antibiotics. Misuse and overuse of these medicines accelerate the problem.
At the 2024 United Nations General Assembly, countries agreed on a series of targets to tackle AMR by 2030. However, experts warn that the growing threat could undermine decades of medical progress.
"Procedures we now take for granted become far riskier when antibiotics and antimicrobials no longer work," Jean-Pierre Nyemazi, acting director of WHO's AMR department, said. The development of new antibiotics is also failing to keep pace with the spread of resistance, he added, Reuters reported.
"Unlike COVID-19, which was very visible, drug-resistant infections have been taking people's lives for years without us noticing it and raising the alarm as we should," Nyemazi said at the forum.
In 2021 alone, AMR was directly responsible for more than one million deaths and associated with approximately 4.7 million others, according to WHO figures.
The 2026 survey highlighted major gaps in infection prevention, a key measure for reducing the need for antibiotics.
The WHO reported that 128 countries now have national infection prevention and control programmes and guidelines, up from 90 in 2018. However, only 69 countries, or 38%, have implemented these programmes nationwide, well below the 2030 target of 90%.
Read More: 98 Years After Penicillin: Are We Running Out Of Effective Antibiotics?
Laboratory capacity also remains limited. While 131 countries reported having national reference laboratories capable of testing antibiotic resistance in common bacteria, only 66 could test for both bacterial and fungal resistance. Countries have agreed to ensure that 80% have these capabilities by 2030.
The WHO also released two toolkits to help countries strengthen diagnostic capacity, covering essential tests and laboratory procedures.
Surveillance has improved, with 113 countries now monitoring antibiotic use and 109 tracking antimicrobial resistance, compared with 65 and 39, respectively, in 2017.
However, only 21 countries reported integrating data on antibiotic use and resistance. The WHO said combining these datasets is essential to understand how antibiotic consumption drives resistance and to guide efforts to contain it.
Antibiotics treat bacterial infections but do not work against viral infections, which commonly cause cold- and flu-like symptoms. Unnecessary use can also expose patients to side effects and contribute to antimicrobial resistance.
As per the WHO, resistance exists across 22 different antibiotics—the common drugs used to treat everyday illnesses, such as:
When bacteria develop resistance, infections become harder to treat, increasing the risk of complications and limiting available treatment options.
(With inputs from agencies)
Credit: iStock
NASA scientists warn that the developing 2026–27 El Niño could rival or surpass the powerful 1997–98 event, which triggered severe droughts, fires and flooding worldwide.
The new findings amid climate deliberations taking place at the COP31 in Turkiye.
Using 35 years of satellite observations, researchers are comparing the current event with previous strong El Niños. The climate phenomenon, marked by warmer-than-average sea-surface temperatures in the central and eastern equatorial Pacific, can disrupt weather patterns worldwide and raise global temperatures.
The 1997–98 and 2015–16 events were among the strongest on record, bringing fires to Indonesia and the Amazon, droughts in southern Africa, and heavy rainfall in Southern California.
Also read: El Niño Could Worsen Dengue, Malaria And Heat Illness: Why WHO Declared A Health Emergency
Satellite altimetry measures changes in ocean surface height, helping scientists track heat accumulation in the Pacific. Warmer seawater expands, raising sea levels.
"What's unique about altimetry is that we have a 35-year record from nearly identical satellites flying almost the same ground track, with each mission overlapping the next," said Josh Willis, project scientist for sea level missions at NASA's Jet Propulsion Laboratory (JPL). "That lets us look back in time and compare this El Niño to what happened in 1997. And right now, this one is on track to be even bigger."
NASA's October measurements show similarities between the two events, including lower sea levels in the western Pacific, higher levels in the east and unusually warm water extending towards South America.
These patterns raise the possibility of similar weather effects, including substantial rainfall across California and the southern United States this winter.
Read More: Climate Crisis Is A Health Crisis: Just 6 Actions Could Save 1.6 Million Lives, Says WHO
NOAA's October 8 outlook estimated an 83% chance of strong to very strong El Niño conditions during the first three months of 2027.
On November 12, its Climate Prediction Center classified the event as "very strong", the highest of four intensity categories. Only three other events since 1950 have reached this level: 1982–83, 1997–98 and 2015–16.
However, El Niño's effects vary by region and do not guarantee the same weather extremes everywhere.
The World Meteorological Organization (WMO) warns that El Niño could amplify climate change-related health risks, including:
A World Food Programme (WFP) analysis published in October projected that El Niño could push 49 million additional people into acute food insecurity by the end of 2027, taking the global total from 225 million to 274 million.
At least 45 countries could experience worsening food insecurity, particularly communities dependent on rain-fed agriculture. WFP warns that the effects could persist through 2027 and into early 2028.
© $2026 Times Horizon Private Limited